Compartmentalization and transport in beta-lactam antibiotics biosynthesis by Evers, M.E et al.
  
 University of Groningen
Compartmentalization and transport in beta-lactam antibiotics biosynthesis
Evers, M.E; Trip, H.; van den Berg, M.A.; Bovenberg, R.A.L.; Driessen, A.J.M.
Published in:
Molecular Biotechnolgy of Fungal beta-Lactam Antibiotics and Related Peptide Synthetases
DOI:
10.1007/b99259
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Publication date:
2004
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Evers, M. E., Trip, H., van den Berg, M. A., Bovenberg, R. A. L., & Driessen, A. J. M. (2004).
Compartmentalization and transport in beta-lactam antibiotics biosynthesis. In A. A. Brakhage (editor),
Molecular Biotechnolgy of Fungal beta-Lactam Antibiotics and Related Peptide Synthetases (Vol. 88, blz.
111 - 135). Berlin: Springer. https://doi.org/10.1007/b99259
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Compartmentalization and Transport 
in b-Lactam Antibiotics Biosynthesis
M. E. Evers1 · H. Trip 1 · M. A. van den Berg 2 · R. A. L. Bovenberg 2 · 
A. J. M. Driessen1
1 University of Groningen, Department of Molecular Microbiology & Groningen Biomole-
cular Sciences and Biotechnology Institute, Kerklaan 30, 9751 NN Haren, The Netherlands
m.e.evers@biol.rug.nl · a.j.m.driessen@biol.rug.nl
2 DSM Anti-infectives, A. Fleminglaan 1, 2611 XT Delft, The Netherlands 
marco.berg-van-den@dsm.com · roel.bovenberg@dsm.com
1 Introduction  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
2 Localization of Biosynthesis Enzymes of the Penicillin Biosynthesis 
Pathway  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
2.1 d-(L-a-Aminoadipyl)-L-cysteinyl-D-valine Synthetase (ACVS)  . . . . . . . . 114
2.2 Isopenicillin N Synthase (IPNS)  . . . . . . . . . . . . . . . . . . . . . . . . 115
2.3 Acyl-Coenzyme A: Isopenicillin N Acyltransferase (IAT)  . . . . . . . . . . . 115
2.4 Side Chain Activation  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
2.5 Localization of Enzymes of Cephalosporin Biosynthesis and Other b-lactams 116
3 Compartmentalization of Penicillin Biosynthesis  . . . . . . . . . . . . . . 117
4 Synthesis of b-lactam Precursors  . . . . . . . . . . . . . . . . . . . . . . . 118
4.1 L-a-Aminoadipate Synthesis  . . . . . . . . . . . . . . . . . . . . . . . . . . 118
4.2 Cyclization of L-a-Aminoadipate  . . . . . . . . . . . . . . . . . . . . . . . 120
4.3 Cysteine Synthesis  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
4.4 Valine Synthesis  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
5 Uptake of b-Lactam Precursors from the Growth Medium  . . . . . . . . . 123
5.1 Uptake of Amino Acids  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
5.2 Uptake of Sulfate and Phosphate  . . . . . . . . . . . . . . . . . . . . . . . . 125
5.3 Uptake of Nitrogen-Containing Compounds  . . . . . . . . . . . . . . . . . 126
5.4 Uptake of Side Chain Precursors  . . . . . . . . . . . . . . . . . . . . . . . . 126
5.5 Uptake of Sugars  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
6 Transport Across the Microbody Membrane  . . . . . . . . . . . . . . . . . 128
7 Excretion of b-lactams into the Medium  . . . . . . . . . . . . . . . . . . . 129
8 Concluding Remarks  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
References  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
Adv Biochem Engin/Biotechnol (2004) 88: 111–135
DOI 10.1007/b99259
© Springer-Verlag Berlin Heidelberg 2004
Abstract Classical strain improvement of b-lactam producing organisms by random mu-
tagenesis has been a powerful tool during the last century. Current insights in the bio-
chemistry and genetics of b-lactam production, in particular in the filamentous fungus Peni-
cillium chrysogenum, however, make a more directed and rational approach of metabolic
pathway engineering possible. Besides the need for efficient genetic methods, a thorough un-
derstanding is needed of the metabolic fluxes in primary, intermediary and secondary me-
tabolism. Controlling metabolic fluxes can be achieved by adjusting enzyme activities and
metabolite levels in such a way that the main flow is directed towards the desired product.
In addition, compartmentalization of specific parts of the b-lactam biosynthesis pathways
provides a way to control this pathway by clustering enzymes with their substrates inside
specific membrane bound structures sequestered from the cytosol. This compartmental-
ization also requires specific membrane transport steps of which the details are currently
uncovered.
Keywords b-Lactam · Biochemical engineering · Compartmentalization ·
Penicillium chrysogenum · Transporter proteins
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Industrial penicillin and cephalosporin fermentation is performed using fila-
mentous fungi. However, sequence analysis of one of the biosynthesis genes en-
coding isopenicillin N synthase (pcbC) of various organisms involved in the
biosynthesis of these compounds, suggests that the origin of these genes stems
from prokaryotic organisms. In bacteria apparently the production of b-lac-
tams has evolved as a means of improving their ability to compete with other
prokaryotes.Via horizontal gene transfer, biosynthetic genes may have been ac-
quired by filamentous fungi some 370 million years ago [1–4]. The advantage
for these fungi of possessing these genes is thought to be of ecological signifi-
cance. Antibiotic production provides fungi with the possibility to protect re-
leased enzymes and released nutrients against bacteria competing for the same
substrates. Other explanations are found in detoxification mechanisms, for in-
stance, to prevent the accumulation of acids such as phenylacetic acid in the cell
[5].After the discovery of the application of penicillin as an antimicrobial agent
in humans in the early 1940s, classical strain improvement has been applied to
obtain higher production yields. High production and secretion of the b-lac-
tams, however, drains intracellular pools of primary metabolites. In addition,
specific metabolic engineering of industrial strains has been applied; however,
this requires extensive knowledge of control of the metabolic fluxes in order to
obtain predictive models and the desired results. The importance of compart-
mentalization and transport processes in industrial penicillin biosynthesis has
become clear and the different aspects of these topics are being studied in sev-
eral laboratories. The aim of this chapter is to describe recent developments
that are important towards the compartmentalization and transport in b-lac-
tam antibiotics by filamentous fungi. The localization of biosynthesis enzymes
and the compartmentalization of biosynthesis, precursors, intermediates and
products will be discussed in relationship to their consequences for intra- and
extracellular transport.
2
Localization of Biosynthesis Enzymes of the Penicillin Biosynthesis 
Pathway
Figure 1 in brief depicts the major enzymatic steps involved in b-lactam
biosynthesis. This section discusses the cellular localization of the key enzymes.
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2.1
d-(L-a-Aminoadipyl)-L-cysteinyl-D-valine Synthetase (ACVS)
The first step in the biosynthesis of penicillins and cephalosporins is the con-
densation of three precursor amino acids, namely L-a-aminoadipate, L-cysteine
and L-valine into the tripeptide d-(L-a-aminoadipyl)-L-cysteinyl-D-valine
(LLD-ACV). This step is catalysed by a multi-enzyme complex of 424 kDa with
non-ribosomal peptide synthetase activity termed ACV synthetase (ACVS)
[6–10]. ACVS is encoded by the acvA gene that is part of a cluster which in-
cludes the other two key enzymes of the penicillin biosynthesis pathway. The
localization of ACVS has been a matter of debate for some time. Initially, it was
described as a membrane associated protein and found to co-sediment with
vesicles of either Golgi or vacuolar origin [11–13]. However, the amino acid se-
quence of P. chrysogenum ACV synthetase contains no recognizable targeting
information for the endoplasmic reticulum or the vacuole, and although the
protein is hydrophobic of nature, it does not harbour any trans-membrane re-
gions. Localization studies by traditional fractionation experiments were ob-
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Fig. 1 Localization of the penicillin biosynthesis; d-(L-a-aminoadipyl)-L-cysteinyl-D-valine
synthetase (ACVS) and isopenicillin N synthase (IPNS) are present in the cytosol (C)
whereas acyl-coenzyme A:isopenicillin N acyltransferase (IAT) and possibly also pheny-
lacetyl-coenzyme A ligase (PCL) are localized in peroxisomes (P). In the mitochondria (M),
part of the synthesis of precursor amino acids takes place
scured by the fact that ACVS is a highly unstable enzyme and very sensitive to
proteolytic degradation. For this purpose improved protocols of cell lysis were
designed and used in combination with an immuno-gold electron microscop-
ical analysis to determine the subcellular location of this protein. On the basis
of these studies, ACVS turned out to be a cytosolic enzyme [11–14]. Likewise,
an ACVS fusion with green fluorescent protein in Aspergillus nidulans also lo-
calizes to the cytosol [15]. The cytosolic localization is more in pair with the pH
optimum of this enzyme, as the acidic vacuole would not support activity.
Moreover, the vacuole is highly proteolytic which seems contradictory with the
protease sensitivity of the multidomain ACVS and the release of a product
tripeptide. ACVS consists of three major modules, one for each amino acid.
These modules are divided into domains that are specialized for partial reac-
tions of the total condensation reaction, hereby combining adenylation activ-
ity, peptide-bond formation, epimerization and product release by thioesterase
activity, in one multi-enzyme [7]. The localization of ACVS in the cytosol bears
consequences for the recruitment of the three precursor amino acids. In gen-
eral, acquisition of L-a-aminoadipate, L-cysteine and L-valine can either pro-
ceed through de novo synthesis or uptake from the growth medium; see below.
2.2
Isopenicillin N Synthase (IPNS)
The second step in b-lactam synthesis is the oxidative cyclisation of LLD-ACV
into isopenicillin N (IPN). In this step, the bicyclic penam nucleus, consisting
of the b-lactam and thiazolidine rings is generated [3, 7]. This step is mediated
by IPN synthase (IPNS) a protein of 38 kDa that is encoded by the ipnA gene that
is part of the penicillin biosynthesis gene cluster. From X-ray diffraction ex-
periments using the substrate analogue d-(L-a-aminoadipoyl)-L-cysteinyl-L-S-
methyl-cysteine in the crystal it was concluded that closure of the b-lactam ring
precedes the closure of the five-membered thiazolidine ring [3, 16]. Based upon
the results of fractionation experiments it became evident that IPNS behaves
like a soluble, cytosolic enzyme [17]. This means that LLD-ACV produced by
ACVS can directly be used as the substrate for IPNS. The question if these two
enzymes are organized in a metabolon or large complex is not known.
2.3
Acyl-Coenzyme A: Isopenicillin N Acyltransferase (IAT)
The third and final step in b-lactam synthesis is the exchange of the L-a-
aminoadipate for phenylacetyl- or phenoxyacetyl group by acyl-coenzyme
A:isopenicillin N acyltransferase (IAT) resulting in the formation of respectively
penicillin G and penicillin V [18–21]. IAT is a hetero-dimeric enzyme consist-
ing of a 11 kDa a-subunit and a 28 kDa b-subunit. It is synthesized as a 40 kDa
pre-protein from the aat gene and undergoes autocatalytic processing to form
the heterodimer [22, 23]. Both subunits possess a C-terminal PTS1 signal that
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targets this enzyme to a microbody or peroxisome. Fractionation studies as
well as immuno-gold labelling experiments indeed localized IAT to micro-
bodies [17]. Consequently the substrate IPN has to enter the microbody before
it can be converted. It is not known yet whether this occurs by diffusion over
the membrane, or by facilitated or active transport.
2.4
Side Chain Activation
Before the side chain can be used in the substitution reaction catalysed by IAT
mentioned above, PA and POA, the side chain precursors, have to be activated
to their CoA thioesters. Theoretically this activation can be carried out by an
enzyme displaying either acetyl-coenzyme A synthetase (ACS) activity, phenyl-
acetyl-coenzyme A ligase (PCL) activity, or alternatively via a glutathione-de-
pendent pathway involving glutathione S-transferase (GST) activity. This phe-
nomenon has not well been studied, but current view considers the last option
unlikely. A gene encoding a cytosolic ACS of P. chrysogenum has been identi-
fied and isolated. Disruption of this gene did not result in a decrease in peni-
cillin production, meaning that ACS cannot be solely responsible for activation
of precursors [17, 24]. In another study a PCL of P. chrysogenum containing a
C-terminal peroxisomal targeting signal (PTS1; SKI) was identified [25]. This
suggests a peroxisomal location of the activating enzyme which would seem
advantageous as it is then in the same compartment as IAT and the peroxiso-
mal concentration of activated precursors would be higher than in the cytosol.
In addition PA and POA are more likely to easily diffuse across the peroxiso-
mal membrane than their activated counterparts thereby providing a means of
retention. However, overproduction of a presumably cytosolic located heterol-
ogous PCL from Pseudomonas putida U increased the penicillin production by
100% whereas overproduction of the homologous peroxisomal PCL of P.
chrysogenum did not affect penicillin production [25, 26]. Although these re-
sults give an ambiguous view on this step, a bias towards a role of the peroxi-
somal PCL is provided by additional observations that will be described below.
2.5
Localization of Enzymes of Cephalosporin Biosynthesis and Other b-lactams
Cephalosporins and cephamycins are produced by the filamentous fungus
Acremonium chrysogenum (syn. Cephalosporium acremonium) (cephalosporin
C), and by Gram-positive actinomycetes such as Nocardia lactamdurans and
Streptomyces clavuligerus (cephamycin C) [27, 28]. Cephalosporin and peni-
cillin biosynthesis have the first two steps in common, i.e. the formation of ACV
by ACV synthetase and the subsequent cyclization to isopenicillin N by IPN
synthase. Here the penicillin and cephalosporin pathways diverge.
Cephalosporin biosynthesis proceeds with the epimerisation of IPN into peni-
cillin N by epimerase activity of the cefD1 and cefD2 gene products in C. acre-
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monium [29] and the completely different cefD gene product in N. lactamdu-
rans and St. clavuligerus [27, 30]. After epimerisation, penicillin N undergoes
expansion of the thiazolidine ring to a dihydrothiazine ring by deacetoxy-
cephalosporin C synthetase, yielding deacetoxycephalosporin C (DAOC).
DAOC is hydroxylated by DAC synthase to give deacetylcephalosporin C (DAC).
In the cephamycin producers N. lactamdurans and St. clavuligerus, DAC is car-
bamoylated and methoxylated to form cephamycin C [31]. In C. acremonium,
DAC is acetylated by the cefG-gene encoded enzyme DAC acetyltransferase [32,
33], yielding cephalosporin C. IPN epimerase, DAOC synthetase, DAC synthase
and DAC acetyltransferase behave as soluble cytosolic proteins with pH optima
above 7.0, reviewed in [34]. Currently, these enzymes are believed to be local-
ized in the cytosol, but no direct studies have addressed the compartmental-
ization issue. Expression of the expandase gene of St. clavuligerus (cefE) or the
C. acremonium expandase-hydroxylase gene and the acetyl transferase gene in
P. chrysogenum and feeding adipic acid has led to efficient production of
adipoyl-7-aminodeacetoxycephalosporanic acid (ad-7-ADCA) and adipoyl-7-
aminocephalosporanic acid (ad-7-ACA) respectively. Removal of the adipyl
side chain gives 7-ADCA and 7-ACA, respectively, which are important inter-
mediates in the production of semi-synthetic cephalosporins [35, 36].
3
Compartmentalization of Penicillin Biosynthesis
As can be concluded from the above the first two steps of penicillin biosyn-
thesis, the condensation into the tripeptide and the conversion into isopeni-
cillin N, take place in the cytosol of filamentous fungi. The final step, side chain
exchange and most probably the side chain precursor activation take place in
the microbody. Microbodies (also termed peroxisomes, glyoxysomes, glyco-
somes depending on the organism and function) are indispensable organelles
that can be found in practically all eukaryotic cells.Although their morphology
is relatively simple (a proteinaceous matrix surrounded by a single membrane)
their physiological properties are remarkably complex. The organelles are in-
volved in pathways of primary, intermediary and secondary metabolism. They
may be regarded as organelles in which specific metabolic conversions take
place mostly by non-membrane bound enzymes. Various peroxisomal meta-
bolic pathways function in the cytosol of peroxisome-deficient mutants, al-
though in some cases with lower final cell yield compared to wild-type cells [26,
37]. For other peroxisomal pathways, the membrane needs to function as an in-
tact boundary, otherwise metabolic pathways may be severely affected even
though all the enzymes of the pathway are synthesized and active in the cytosol
[38]. A general major advantage of the presence of a peroxisomal permeabil-
ity barrier is that it permits the cells to precisely adjust the levels of different
intermediates of primary metabolism required for specific metabolic pathways
(metabolic flux control by a physical barrier). It was in 1991 that the importance
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of the microbody with respect to penicillin biosynthesis (secondary metabo-
lism) became evident when IAT was shown to be located in this organelle [17].
When the putative targeting signal was removed the enzyme was not directed
to the microbody but instead localized in the vacuole and surrounding cytosol.
Under these conditions, production of penicillin was halted although the en-
zyme was expressed in vivo and active in vitro [39]. This might be explained
by the possibility that another essential enzymatic step, the precursor activa-
tion by PCL might occur only inside microbodies and that these activated pre-
cursors are now sequestered from IAT inside the microbody. The other expla-
nation, namely that IAT is not able to perform the catalytic reaction in the
cytosol seems less likely, because in a mutant of A. nidulans lacking functional
peroxisomes, penicillin production still occurred with the peroxisomal en-
zymes mislocalized to the cytosol [40].Although this suggests that peroxisomes
are not essential for penicillin production per se, a positive correlation between
penicillin yield and peroxisome numbers has been implicated [17]. The exact
reason for this correlation is not known, but this may relate to an increase in
the amount of enzymes of the biosynthesis pathway. For detailed information
on import of peroxisomal proteins and biogenesis of peroxisomes see reviews
by Purdue et al. [41] and van der Klei et al. [42] and references therein.
4
Synthesis of b-lactam Precursors
4.1
L-a-Aminoadipate Synthesis
L-a-Aminoadipate is an intermediate of the L-lysine biosynthesis pathway. The
intracellular level of L-a-aminoadipate can be a limiting factor in the overall
penicillin synthesis rate, as shown by the observation that addition of L-a-
aminoadipate to the growth medium enhances the b-lactam production [43].
Therefore, the lysine biosynthsisc pathway is extremely important for, and in-
terconnected with, the b-lactam biosynthesis pathway. Recent insights in the ly-
sine biosynthesis route in yeast may alter the classical view on this pathway sig-
nificantly. L-Lysine biosynthesis starts with the condensation of acetyl-CoA and
a-ketoglutarate into homocitrate by homocitrate synthase. This enzymatic re-
action was until recently believed to take place in the mitochondria of P. chryso-
genum because of insights in this route in higher eukaryotes. However, a lo-
calization study using a GFP-fusion of homocitrate synthase indicates that in P.
chrysogenum this protein is located in the cytosol, although it could not be ex-
cluded that minor amounts might be present in the nucleus and mitochondria
[44]. Using an in silico approach by performing a Saccharomyces cerevisiae
database context sensitive motif search to identify new peroxisomal proteins,
it was established that both the LYS1 and LYS4 proteins that encode a homoa-
conitase and a saccharopine dehydrogenase, respectively, contain a C-terminal
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peroxisomal targeting signal (PTS1). GFP-fusions of these proteins localized to
peroxisomes. This suggests that these proteins are peroxisomal localized [44,
45] (Fig. 2). Furthermore, examination of micro-array experiments to deter-
mine the role of peroxisomes under physiological conditions revealed that in
a peroxisome-deficient mutant five genes of the lysine biosynthesis pathway are
highly up-regulated, among them LYS1 and LYS4. The other three genes that are
up-regulated are LYS20 (homocitrate synthase), LYS12 (homoisocitrate dehy-
drogenase) and LYS9 (another saccharopine dehydrogenase). LYS12 contains a
putative PTS1 whereas LYS9 and LYS20 contain PTS2-like sequences. The ob-
served expression pattern of the genes of a peroxisome-deficient mutant grown
on rich medium surprisingly resembled a lysine starvation response even when
sufficient lysine was present in the medium. The authors explain their findings
by mislocalization of a-aminoadipate semialdehyde to the cytosol. When 
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Fig. 2 Compartmentalization of lysine biosynthesis in relation to penicillin biosynthesis. a-
Aminoadipate is a branch point intermediate at which the lysine and penicillin biosyn-
thesis routes converge. In the last step of the penicillin biosynthesis, the a-aminoadipate
moiety of isopenicillin N (IPN) is exchanged for phenylacetic acid and becomes available
again for penicillin or lysine biosynthesis. Part of a-aminoadipate is lost by the cyclization
into 6-oxopiperidine-2-carboxylic acid (OPC). OPC is excreted into the medium by an un-
known mechanism. Main routes are depicted in bold arrows, hypothetical routes are in light
grey. PM, plasma membrane
a-aminoadipate semialdehyde is not contained inside the peroxisome the level
in the cytosol will increase and stimulate the Lys14p transcriptional activator
[46]. In contrast, no peroxisomal PTS could be detected in Lys5p or in the amino
acid aminotransferases that are thought to be a part of the lysine biosynthetic
pathway.Therefore, it is believed that it is not very likely that all the lysine biosyn-
thesis enzymes have an exclusively peroxisomal location,and that part of the path-
way may be cytosolic [46].The question arises if these proteins are also localized
in the peroxisomes of P. chrysogenum,which is important for the question where
the L-a-aminoadipate is formed? Consequently, a peroxisomal location poses
some important questions about the mechanism of release of L-a-aminoadipate,
as this charged amino acid is unlikely to pass the membrane passively.
4.2
Cyclization of L-a-Aminoadipate
During b-lactam biosynthesis, part of the a-aminoadipate is lost by the irre-
versible formation of 6-oxopiperidine-2-carboxylic acid (OPC), the cyclized
d-lactam of a-aminoadipate. This compound is excreted into the medium.
The extent of OPC formation ranges from 6 to 60% relative to the formation of
penicillin (on a molar basis), depending on strain and cultivation conditions.




The synthesis of cysteine in P. chrysogenum is dependent on the active uptake
of sulfate from the exterior of the cell. The sulfate assimilation pathway cata-
lyses the reduction of sulfate via sulfite to sulfide and subsequently sulfide is
converted into cysteine (Fig. 3). The reduction of sulfate into sulfite is catalysed
by three enzymes: ATP sulfurase converts inorganic sulfate into adenosine-5-
phosphosulfate (APS) which is then activated into 3-phospho-adenosine-5-
phosphosulfate (PAPS) by APS-kinase and reduced to sulfite by PAPS reductase
[48–50]. Sulfite is reduced to sulfide by sulfite reductase [51]. The location of en-
zymes involved in the reduction of sulfate has not been described.
Sulfide is the basis for biosynthesis of L-cysteine, which occurs via two dif-
ferent pathways in b-lactam producing fungi: the transsulfuration and the
sulfhydrylation pathway. L-Cysteine, synthesized via the transsulfuration path-
way, is formed by cleavage of L-cystathionine derived from the intermediate L-
homocysteine, which is formed from L-methionine or O-acetyl-L-homoserine
[52]. Otherwise, direct acetylation of L-serine yields O-acetyl-L-serine that, in
the presence of sulphide, is converted to L-cysteine by action of the enzyme O-
acetyl-L-serine sulfhydrylase (OASS). Theoretically, the yield of penicillin on
glucose would be substantially higher when L-cysteine is synthesized exclu-
sively via the direct sulfhydrylation pathway [53, 54]. In A. nidulans and C. acre-
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monium both pathways are described, although A. nidulans prefers the direct
sulfhydrylation, while C. acremonium utilizes the transsulfuration pathway [55,
56]. For the industrial penicillin producer P. chrysogenum only the presence of
the transsulfuration pathway was demonstrated as mutants, disturbed in this
pathway, were unable to grow on inorganic sulfate [57], which is the main
source of sulfate during industrial fermentations. Recently, Østergaard et al.
[58] reported the purification of OASS from P. chrysogenum. This enzyme is lo-
calized in the mitochondria (van den Berg MA,Westerlaken I, Hillekens R and
Bovenberg RAL, unpublished results) and the analogous enzyme of the
transsulfuration pathway, O-acetyl-L-homoserine sulfhydrylase (OAHS), is lo-
cated in the cytosol. Moreover, a cloned cDNA encoding OASS was fused to
eGFP and shown to encode active OASS enzyme located in the mitochondria
(van den Berg MA., Westerlaken I., Hillekens R. and Bovenberg RAL, unpub-
lished results). Isolated UV mutants that were unable to grow on inorganic sul-
fate unless OAS, or a more reduced sulfate source like cysteine or methionine,
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Fig. 3 Sulfate uptake and metabolism in P. chrysogenum. PM, plasma membrane
was added to the medium are likely to be disturbed in serine transacetylase.
These findings suggest a distinctive role of the direct sulfhydrylation pathway
for growth. This in contrast to the cytosolic transsulfuration pathway, which
seems to be used for penicillin production in P. chrysogenum, as an increase in
detectable OAHS activity correlates with the onset of penicillin G biosynthesis
in shake flask experiments (van den Berg MA, Westerlaken I, Hillekens R and
Bovenberg RAL, unpublished results).
4.4
Valine Synthesis
Valine synthesis starts with the condensation of pyruvate with hydroxyethyl
thiamine pyrophosphate into a-acetolactate by Acetohydroxy acid synthase.
The conversion of a-acetolactate into L-valine is catalysed by three enzymes.
Acetohydroxy acid isomeroreductase converts a-acetolactate into dihydroxy-
isovalerate. Dihydroxy acid dehydrase converts dihydroxyisovalerate into a-ke-
toisovalerate which in turn is converted to L-valine by the branched chain
amino acid Glutamate transaminase.
All four enzymes are thought to be located inside the mitochondrial matrix
[59]. Consequently valine has to be translocated to the cytosol to become avail-
able for ACVS. The mechanism by which amino acids that are synthesized in-
side the mitochondrial matrix are transported into the cytosol has not been in-
vestigated. The inner membranes of mitochondria contain a family of
transporter proteins (the mitochondrial carrier family) of related sequence and
structure that are involved in the uptake and excretion of various metabolites,
nucleotides and cofactors [60, 61] (and references therein). A number of these
transporters have been biochemically characterized by overexpression and
functional reconstitution into liposomes, most notably the ATP/ADP translo-
case and the phosphate transporters. The mitochondrial transporters operate
by various mechanisms, which include uniport, symport, and antiport mecha-
nisms [62] (and references therein). As to amino acid transport, a few trans-
porters have been biochemically characterized: two human aspartate-glutamate
transporters, citrin and aralar1, mediate the antiport of aspartate for glutamate
[63]; a human glutamate transporter, GC, catalyses the uptake of glutamate in
symport with protons [60], and an ornithine transporter from rat liver mito-
chondria that catalyses the uptake of ornithine in an antiport reaction for cit-
rulline or protons [64]. In S. cerevisiae, an ornithine transporter,ARG11, medi-
ates the exchange of ornithine for protons, but transports also arginine and
lysine with less affinity [65]. The genomic sequence of S. cerevisiae suggests
presence of 35 putative members of the mitochondrial transporter family and
an increasing number can now be associated with a particular transport reac-
tion [60, 66] (and references therein). It is unknown how valine, cysteine and a-
aminoadipate are transported across the mitochondrial inner membrane. In-
terestingly, one member of the mitochondrial carrier family in S. cerevisiae
turned out to be an adenine nucleotide transporter in peroxisomes [67].
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5
Uptake of b-Lactam Precursors from the Growth Medium
5.1
Uptake of Amino Acids
Since penicillin and cephalosporin are synthesized from three amino acid pre-
cursors, amino acids might play an important role in the regulation of b-lac-
tam synthesis. This may be either directly, e.g. precursor availability for ACV
synthesis, or indirectly, e.g. by affecting expression of penicillin synthesis genes.
All amino acids are synthesized by filamentous fungi, but can also be taken up
from the extracellular medium and be used as nitrogen and carbon source. In
industrial P. chrysogenum fermentations for penicillin production, corn steep
liquor is often used as nitrogen source. This supplement is rich in amino acids,
which are consumed in the exponential phase of a fed-batch cultivation, rather
than ammonia.When the amino acids are depleted the cells start to utilize am-
monia as the nitrogen source [68].
A number of effects of the addition of extracellular amino acids on b-lactam
synthesis have been reported.The addition of the three amino acid precursors a-
aminoadipate, cysteine and valine to P. chrysogenum in nitrogen-less medium
leads to efficient incorporation into ACV.Only a-aminoadipate increases the rate
of ACV synthesis and the overall penicillin synthesis rate [43, 68]. Based on such
studies, it was suggested that the intracellular a-aminoadipate concentration may
be limiting for the penicillin biosynthesis [69].The addition of lysine to P. chryso-
genum and A. nidulans cultures leads to a reduction of penicillin biosynthesis
[70]. L-Lysine inhibits homocitrate synthase, the first enzyme in the lysine biosyn-
thesis pathway, thereby blocking the production of a-aminoadipate,which is the
branch-point metabolite between the lysine and penicillin biosynthetic pathways
[71]. Lara et al. reported a stimulating effect on penicillin synthesis by addition
of L-glutamate in minimal media. Interestingly, this effect was also observed with
non-metabolisable analogues of L-glutamate [72].
The effect of externally added amino acids on the expression of penicillin
biosynthesis genes acvA and ipnA was investigated in A. nidulans. The negative
effect of histidine and valine is due to a reduced activation of the transcriptional
factor PACC under acidic conditions. The presence of these amino acids leads to
a decreased ambient pH during cultivation of the fungus. The negative effect of
lysine and methionine, that also cause an acidification of the medium, does not
involve PACC. The mechanism by which these amino acids act is unclear [73].
In Acremonium chrysogenum, the addition of DL-methionine to the medium
led to increased mRNA levels of cephalosporin biosynthesis genes pcbAB
(acvA), pcbC (ipnA) and cefEF, encoding deacetylcephalosporin C syn-
thetase/hydroxylase and a three- to fourfold increase in the production of
cephalosporin C [74, 75].
Uptake of amino acids in filamentous fungi is mediated by active amino acid
permeases. In general, fungi possess a multiplicity of amino acid permeases
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that are involved in the uptake of amino acids from the environment as nitro-
gen and/or carbon source or as building blocks for the synthesis of proteins
and peptides [76]. Biochemical and genetic characterization of fungal amino
acid transporters has been performed most extensively in S. cerevisiae. Most
fungal amino acid permeases show significant sequence similarities and form
a unique family referred to as the AAP family [77], a subfamily of the APC fam-
ily [78]. The permeases have a common structural organization with 12 puta-
tive a-helical transmembrane segments and cytoplasmically located N- and C-
terminal hydrophilic regions [79–81]. Uptake occurs as secondary transport, i.e.
by proton symport, with the pmf as driving force in order to allow uptake
against the concentration gradient [77, 78, 82]. An exception is an amino acid
permease encoded by the mtr locus of Neurospora crassa [83, 84]. This perme-
ase is unrelated to the AAP family, but instead it belongs the amino acid/auxin
permease (AAAP) family [85]. Recently, a functional and structural homologue
of the mtr encoded permease was found in P. chrysogenum (unpublished re-
sults). Genome analysis of S. cerevisiae revealed 24 members of the AAP fam-
ily, of which most have been functionally characterized [79]. Some of them are
specific for one or a group of related L-amino acids, such as Dip5p (glutamate
and aspartate), Put4p (proline), Can1p (arginine). Others have a broader speci-
ficity, like Agp1p, which transports most neutral amino acids [79, 86].The gen-
eral amino acid permease Gap1p, transports all L-and D-amino acids and non-
proteinogenic amino acids such as citrulline and ornithine [87].
In P. chrysogenum, so far three amino acid permeases have been cloned and
characterized [88]; (Trip et al. unpublished results), and various other activities
have been classified on the basis of transport and competition assays. Nine
amino acid transport systems have been reported: system I for L-methionine
[89]; II for L-cysteine [90]; III for all amino acids [91, 92], analogous to Gap1p
of S. cerevisiae; IV for acidic amino acids; V for L-proline; VI for L-lysine and
L-arginine, VII for L-arginine; VIII for L-lysine and IX for L-cysteine [92]. The
first two systems are expressed under sulphur starvation, while systems III-V
are expressed under nitrogen and carbon starvation (NCR and CCR). Systems
VI-VIII appear constitutive [76]. System VI was studied by Hillenga et al., 1996
[93], using plasma membranes fused with liposomes containing cytochrome c.
Factors that interfere with the analysis of the plasma membrane transport
processes when performed with intact mycelium, like metabolism and com-
partmentalisation, were circumvented this way. Inhibition studies with ana-
logues revealed a narrow substrate specificity for arginine and lysine and quan-
titative analysis of arginine uptake suggest a H+-arginine symport stoi-
chiometry of one-to-one [93]. Uptake of a-aminoadipate, an acidic amino acid
similar in structure to glutamate, might be mediated by both the acidic amino
acid transport system [92], and general amino acid transport system [76]. The
acidic amino acid permease gene, DipP, was cloned and biochemically charac-
terized. This transporter is homologous to Dip5 of S. cerevisiae [79] and is ca-
pable of transporting a-aminoadipate, albeit with much lower affinity than the
preferred substrates aspartate and glutamate (Km of 800 and 35 mmol/l, re-
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spectively) (H. Trip, unpublished results). Transport studies with penicillin pro-
ducing mycelium show that a-aminoadipate uptake is strongly competed by
leucine which is a substrate for the general amino acid permease, and not for
DipP. This suggests that the general amino acid permease provides the main
route for a-aminoadipate uptake into the cell. The expression of DipP is, like
Dip5 in S. cerevisiae, under nitrogen catabolite repression and is strongly in-
duced when glutamate is the only nitrogen source in the culture medium (H.
Trip, unpublished results). ARLP encodes a permease specific for aromatic
amino acids and leucine [88] and MTRP encodes a permease specific for neu-
tral aliphatic and aromatic amino acids (H. Trip, unpublished results). MtrP is
a structural and functional homologue of the mtr locus encoded protein of N.
crassa and therefore not related to the AAP family, but a member of the AAAP
family [88]. The physiological role of these permeases is unclear. It has been
postulated that the ACV precursors a-aminoadipate, cysteine and valine are se-
questered in the vacuole of P. chrysogenum. Cysteine and valine are produced
in the vacuole due to proteolytic degradation of proteins. The presumed vac-
uolar localization of ACVS would then benefit from a direct withdrawal of these
amino acids from the vacuolar pools [13]. The recent observation that ACVS is
located in the cytosol [14] and the fact that in S. cerevisiae the acidic amino
acids glutamate and aspartate are not accumulated in the vacuole, but instead,
are located almost exclusively in the cytosol [94], do not support the vacuolar
storage of the acidic amino acid a-aminoadipate. In S. cerevisiae, four vacuo-
lar amino acid transporters have been identified, one of which,AVT6, mediates
the efflux of the acidic amino acids glutamate and aspartate from the vacuole.
These transporters do not show homology with amino acid permeases from
the cellular membrane [95].
5.2
Uptake of Sulfate and Phosphate
The uptake of sulfate is an important step in the regulation of sulphur metab-
olism in P. chrysogenum. This uptake has been studied with mycelium and iso-
lated plasma membrane vesicles. These experiments showed that uptake is me-
diated by a electroneutral sulfate/proton symport mechanism [96]. The P.
chrysogenum membrane vesicles were fused with cytochrome-c oxidase con-
taining liposomes to provide the system with a proton motive force. Sulfate up-
take was solely dependent on the transmembrane pH gradient, and occurred
with high affinity (Km~30 mmol/l). Apart from sulfate, the transporter also
showed affinity for analogous divalent oxyanions like thiosulfate, selenate and
molybdate. The genes of two putative sulfate transporters (designated SutA and
SutB), and PAPS reductase (parA) have been cloned and sequenced [28]. SutB
is the major sulfate transporter, while the exact function of SutA remains to be
elucidated. This protein has been implicated in thiosulfate uptake or is possi-
bly involved in an intracellular sulfate uptake activity. Expression studies were
performed to determine if there is a relationship between penicillin biosyn-
Compartmentalization and Transport in b-Lactam Antibiotics Biosynthesis 125
thesis and sulfate metabolism. Under sulphur starvation conditions the ex-
pression levels of both sulfate transporters are elevated. A positive correlation
was observed between the levels of sutB mRNA and the penicillin biosynthe-
sis, but such a correlation was not apparent for sutA and parA mRNAs. The
parA mRNA levels are controlled by the sulphur content of the medium. It is
generally believed that SutB is the main route for sulfate uptake during b-lac-
tam biosynthesis [97].
Phosphate transport in P. chrysogenum has hardly been studied. In fungi up-
take of phosphate occurs through proton and sodium phosphate symport. In
fermentation media phosphate addition does not in itself inhibit penicillin pro-
duction, but it strongly enhances the effect of glucose repression of transcrip-
tion of the genes of the penicillin cluster [98]. In S. cerevisiae at least 5 trans-
porters are involved in this process namely PHO84, 87, 89, 90 and 91. Deletion
of all five genes is lethal [99]. Pho90 and Pho91 have the highest phosphate
transporting capacity, whereas Pho84 and Pho87 are specific phosphate sen-
sors. Pho89 has a very low transporting capacity and is not involved in phos-
phate signalling [99]. Pho84 is a phosphate proton symporter belonging to the
Major Facilitator Superfamily (MFS) proteins and contains 12 membrane span-
ning segments.
5.3
Uptake of Nitrogen-Containing Compounds
Ammonium, nitrate, urea and amino acids are possible nitrogen sources in b-
lactam synthesis. The uptake and synthesis of amino acids has been described
above. Although one of the earliest reports about an active ammonium trans-
port system concerned the uptake of methylammonium by P. chrysogenum
[100], no major new insights have been obtained since then. At high concen-
tration, methylammonium is toxic to cells, and this was used to screen for mu-
tants of S. cerevisiae and A. nidulans that are impaired in methylammonium
uptake [101, 102]. This screen lead to the identification of several genes that en-
code (methyl)ammonium transporters (MEP/AMT). In A nidulans, two am-
monium transporters have been described. These two proteins, MeaA and
MepA are also involved in the retention of ammonium as determined by cross-
feeding studies [103]. Although the molecular mechanism of transport is still
unclear, studies using the LeAMT1 plasma membrane ammonium transporter
of tomato (Lycopersicon esculentum) that was functionally expressed in Xeno-
pus oocytes, indicate that ammonium ions are the substrates rather than am-
monia. Uptake seems to take place by means of a uniport mechanism [104].
5.4
Uptake of Side Chain Precursors
Phenylacetic acid (PA) and phenoxyacetic acid are weak acids that rapidly en-
ter P. chrysogenum cells through passive diffusion and distribute across the
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membrane according to the transmembrane pH gradient [105, 106]. However,
various reports have implicated active transport in the acquisition of phenyl-
acetic acid from the medium [107]. The major differences in these studies
may relate to concentration of phenylacetic acid used, and eventually the type
of strains (low- vs high-yielding strains). When high concentrations of PA
(60–3000 mmol/l) are used, PA readily enters the cells through passive diffusion
in both low- and high-yielding strains. However, at low concentrations
(1.4–100 mmol/l) accumulation of PA in the low yielding strain exceeds the ac-
cumulation of PA in the high yielding by a factor 10 at the lowest concentra-
tions, suggesting the involvement of a transporter protein [108]. However, the
latter may also relate to side-chain activation. Instead of uptake, the activity of
the CoA ligase may be responsible for the observed retention. However, during
b-lactam biosynthesis, high concentrations (millimolar) of PA or phenoxy-
acetic acid are fed to the cells, which makes that passive diffusion will be the
dominating route of entry into the cell.
5.5
Uptake of Sugars
The supply of sugars as the major carbon in industrial fermentation of P.
chrysogenum is of importance, as it accounts for more than 10% of the overall
costs [109]. Moreover, sugar plays an important role in the regulation of peni-
cillin biosynthesis. Glucose and sucrose impose a strong inhibitory effect on b-
lactam production by repression of penicillin biosynthesis genes (acvA and
ipnA in P. chrysogenum, ipnA in A. nidulans) as well as by post-transcriptional
(down)regulation (IAT in A. nidulans) [110]. Lactose does not inhibit b-lactam
biosynthesis, which, for P. chrysogenum, was suggested to be due to the slow hy-
drolysis into glucose and galactose resulting from very low b-galactosidase ac-
tivity [98]. Lactose has been traditionally used for penicillin biosynthesis, but
during industrial fermentation, a limiting glucose-feed is now regularly used,
avoiding carbon source/catabolite regulation [68].
Glucose uptake in fungi has been best studied for S. cerevisiae. Glucose
transport occurs by facilitated diffusion [111] which involves transporters that
belong to the MFS family [112, 113]. A family of 20 different hexose trans-
porters or related proteins (Hxtp) is thought to be involved in sugar transport
and regulation [111, 114]. In a hxt1–7 disruption mutant strain, glucose uptake
is abolished, whereas the expression of any one of the genes HXT1, 2, 3, 4, 6 or
7 can restore glucose uptake [115]. Hxt1p and Hxt3p are low affinity trans-
porters (Km=50–100 mmol/l), Hxt2p and Hxt4p are equipped with a moder-
ately low affinity (10 mmol/l) and Hxt6p and Hxt7p are high affinity glucose
transporters (1–2 mmol/l). A galactose permease was also shown to transport
glucose with high affinity (Km=1–2 mmol/l) [114]. In filamentous fungi, glucose
uptake systems have been described for A. nidulans [114, 116], A. niger [117],
and N. crassa [118–123]. In general, at least two systems appear to be present,
a constitutive, passive, low-affinity system, and a glucose repressible, proton
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motive force-driven, high-affinity system. The high-affinity system generally
has a much lower Km-value than found in S. cerevisiae. The Km for the high-
affinity system in A. nidulans is 0.04–0.06 mmol/l [81, 124]; for P. chrysogenum
a value of 0.2 mmol/l has been reported [125]. Like in S. cerevisiae, more than
two transporter proteins might be involved in glucose transport, but since mu-
tants disrupted in one or more glucose transporter genes are not yet available,
individual characterization is complicated.
Little information is available on lactose transport in fungi. The best char-
acterized fungal lactose uptake system is the inducible LAC12 gene product of
Kluyveromyces lactis [126, 127], which transports lactose in symport with pro-
tons. Proton symport seems to be a general mechanism for disaccharide trans-
port in fungi [126–128]. In P. chrysogenum, lactose is taken up by an energy-de-
pendent system, mostly likely proton motive force-driven system. The lactose
transport activity is induced when cells are growth on lactose (van de Kamp et
al., unpublished).
6
Transport Across the Microbody Membrane
As mentioned previously, some of the enzymatic steps of the penicillin and ly-
sine synthesis pathway take place inside the microbody. The exact reason why
these steps are localized in this intracellular organelle is not clear, but it has been
hypothesized that the microbody lumen provides an optimal environment for
these enzymes for instance with respect to pH, metabolite concentration etc. The
internal pH of peroxisomes in the yeast Hansenula polymorpha has been re-
ported to be acidic (pH 5.8–6) [129]. However, the pH optimum of IAT is in the
alkaline range, and the enzyme is inactive at pH values lower than 6 [130, 131].
The same has been reported for PCL which is likely localized in the microbody.
The pH of P. chrysogenum microbodies has also been investigated with the en-
hanced yellow fluorescent protein (eYFP) that was targeted to the microbody by
means of a C-terminal PTS1 signal SKL. Based on the fluorescence characteris-
tics, it was concluded that the microbody is not acidic, but slightly alkaline
(pH 7.0–7.5) [132]. This is more in accordance with the pH optimum of the
abovementioned biosynthesis enzymes. Studies on microbodies in human fi-
broblasts even suggest that the luminal pH may be as alkaline as pH 8.2 [133].
Other possible advantages for compartmentalization of key enzymatic steps
may relate to the higher concentrations of both enzymes and substrates, the
prevention of draining catalytic intermediates into unwanted side reaction
pathways, and/or regulation of the biosynthesis pathway. The subcellular dis-
tribution of the various enzymatic steps over different organelles poses, how-
ever, important problems towards the transport of the metabolites. For a long
time it was believed that peroxisomes are permeable to small compounds. For
instance, it was not possible to obtain peroxisomes while maintaining the per-
meability barrier of the membrane. Also, a porin-like protein has been found
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to be associated with the peroxisomal membrane [134–137]. However, the in
vivo studies on the luminal pH and identification of various transporters now
suggest that the peroxisomal membrane represents a permeability barrier.
NAD(H), NADP(H), acetyl-CoA, ATP and protons cannot freely pass peroxiso-
mal membranes of different organisms [67, 133, 138, 139]. The necessity for per-
oxisomal membrane proteins (PMPs) with a transport function is therefore
obvious. Biochemical studies, however, have suffered from the fact that the
organelles are very fragile, while PMPs appear of low abundance [140]. Of the
known peroxisomal transporters only one has been studied in detail with
respect to substrate specificity, namely the peroxisomal adenine nucleotide
transporter Ant1p of S. cerevisiae. This system is very homologous to the mito-
chondrial transporter family. Ant1p has been overproduced, purified from the
peroxisomal membrane fractions and reconstituted into liposomes [67]. The
system has been suggested to function as an ATP/AMP antiporter, supply the
microbody lumen with cytosolic ATP. So far, experimental evidence is lacking
for the involvement of transporters in the uptake of IPN and PA or the extrusion
of a-aminoadipate and penicillins.
7
Excretion of b-lactams into the Medium
The mechanism of excretion of b-lactams into the medium has been a subject
of speculation for a long time.Various options need to be considered, i.e., pas-
sive diffusion, vesicular transport and the involvement of transport proteins.
Passive diffusion phenomena are strongly dependent on the physicochemical
characteristics of the membrane, like fluidity, degree of saturation and the acyl
chain length of the lipid fatty acids but also on the intrinsic properties of the
compound, like charge, size and hydrophobicity. Penicillins V and G are am-
phiphatic, moderately hydrophobic molecules and negatively charged at the cy-
tosolic pH. The diffusion of these molecules has been studied in model mem-
branes, and it was suggested that they can permeate a membrane composed of
phospholipids [106]. The permeability characteristics of the membrane were,
however, greatly reduced when sterols were present in the membrane. Since
plasma membranes of P. chrysogenum contain 30% ergosterol, a concentration
that suffices to block most of the passive permeation, passive diffusion seems
very unlikely [106].
During recent years it has become increasingly evident that all living cells
are equipped with multidrug transporters that are capable of expelling unre-
lated, mostly hydrophobic compounds across the membrane. These trans-
porters convey multidrug resistance to cells. Due to the physiochemical char-
acteristics of penicillins, MDR transporters are likely candidates for b-lactam
secretion. MDR transporters can be subdivided into six families (for a review
see [141, 142]). Two of the transporter families have already been implicated in
b-lactam extrusion and will be briefly discussed here; namely the ATP-binding-
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cassettes (ABC) transporter superfamily and the MFS of proteins. The ABC-
transporters form a very large family of proteins with a very broad spectrum
of substrate specificity, they translocate both small and large molecules across
membranes. They are characterized by the presence of two cytosolic nucleotide
binding domains (NBD’s) each containing the highly conserved Walker A and
Walker B motifs that specify the nucleotide binding site, and two transmem-
brane domains consisting of six transmembrane spanning segments [141]. The
MFS is also referred to as the uniporter-symporter-antiporter family. These
proteins are secondary transporters that transport small molecules in a proton
motive force-dependent manner. They can be classified into 17 families. This
includes the drug:H+ antiporter families that specify membrane proteins with
either 12 or 14 membrane spanning segments [142].
Recently, the first experimental evidence has been obtained that secretion
of b-lactam in filamentous fungi may indeed involve active transport. This
concerned a study on the involvement of ABC-transporters of A. nidulans in
drug resistance. After identification of a number of ABC-transporter genes, a
disruption mutant for the atrD gene displayed increased sensitivity towards
the chemically unrelated compounds valinomycin, nigericin and cyclohex-
imide. Moreover, in a halo size assay, used as a measure of the amount of peni-
cillin produced, a reduced penicillin production was detected for an atrD dele-
tion strain [143]. This suggests a role of the ATRDp in penicillin secretion,
although this needs to be verified by direct transport assays. In another study,
the region downstream of the acvS gene of Acremonium chrysogenum was ex-
amined which identified a gene encoding a membrane protein (CefT) be-
longing to the MFS. The deduced protein sequence revealed that this protein
belongs to the family of drug: H+ antiporters with 12 transmembrane seg-
ments. Disruption of the gene showed that it was not required for
cephalosporin synthesis and that growth of A. chrysogenum was not affected.
However, amplification of the full length gene (2 to 4 copies) resulted in a
twofold increase in the cephalosporin C production [29]. Both studies, how-
ever, await direct proof that the identified transporters (AtrD and CefT) me-
diate antibiotic transport.Also in P. chrysogenum, a series of ABC transporters
have been identified that are expressed under penicillin producing conditions
[144]. Some of these MDR-like ABC transporters are induced when cells are
challenged with b-lactam, suggesting a role in b-lactam excretion. In various
antibiotic producing organisms, genes have been identified that confer resis-
tance to the produced antibiotic presumably by transporting the drug out of
the cells. In the gene cluster for antibiotic biosynthesis of Streptomyces
argillaceus the genes mtrA and mtrB are present that encode a putative ABC-
transporter and render the organism resistant to mithramycin [145]. In b-lac-
tam producing actinomycetes like Nocardia lactamdurans genes are found
that code for transporter proteins either belonging to the ABC-transporter su-
perfamily or the MFS [27].
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8
Concluding Remarks
In recent years, major insights have been obtained in the compartmentaliza-
tion of the b-lactam biosynthesis pathway in filamentous fungi. The exact
molecular reasons for the localization of the last step of biosynthesis steps in
a microbody are not known, although the specific pH in this organelle seems
favourable for the catalytic activity of the key enzymes. Control of the cellu-
lar distribution of a-aminoadipate to direct it either into the lysine or peni-
cillin biosynthesis pathway may be crucial now it appears that critical enzy-
matic steps take place in the microbody. However, many of the molecular
details still need to be resolved (see chapter Brakhage et al.). Other questions
concern if b-lactam synthesis is limited by transport process, as for instance,
cellular secretion? Intrinsic to the approach of removing bottlenecks from a
metabolic production process, new limiting factors are found one of which
may related to transport, a process often ignored in metabolic pathway engi-
neering programs.
The antibiotic resistance of bacteria necessitates the discovery and produc-
tion of new antibiotics. Genetic engineering enables us to intervene in meta-
bolic and biosynthetic pathways thereby providing new opportunities of prod-
uct formation. Such challenging metabolic reprogramming efforts also require
insights in critical transport steps and possible limitation by exciting substrate
specificities. Metabolic flux analyses of genetically altered strain, genome se-
quencing and transcriptome profiling, and directed evolution promise to be in-
teresting tools for the near future.
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